Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells.

Journal Information

Full Title: J Immunother Cancer

Abbreviation: J Immunother Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"to further characterize the heterogeneity of cell lines in different states of emt we analyzed their proteomic profile ( online supplemental figure 5a ) and evaluated differentially expressed proteins ( online supplemental table 1 ) using wgcna (deposited to the proteomexchange consortium dataset identifier pxd044297."

Code Sharing
Evidence found in paper:

"Competing interests: None declared."

Evidence found in paper:

"Funding: The study was supported by grants from Italian Ministry of Health (RF-2018-12366714 to MV and GB, RF-2016-02362946 to LR), Fondazione Regionale per la Ricerca Biomedica (Regione Lombardia) (1731093 to GB), the Italian Association for Cancer Research (AIRC IG 25023 to MV, IG 21431 to LR, 23244 to GS), Italian Ministry of Health (5x1000-2018) granted to IRCCS Ospedale Policlinico San Martino). Italian Ministry of Health Ricerca Corrente” funds to Fondazione IRCCS Istituto Nazionale dei Tumori."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025